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Abstract
The longitudinal monitoring of oxidative stress (OS) in athletes may enable the identification
of fatigued states and underperformance. The application of OS biomarker monitoring pro-
grams in sport are hindered by reliability and repeatability of in-the-field testing tools, the
turnaround of results, and the understanding of biological variation (BV). Knowledge of BV
and critical difference values (CDV) may assist with data interpretation in the individual ath-
lete. Methods: We aimed firstly to assess the repeatability of the clinical point of care redox
test, Free Oxygen Radical Test (FORT) and the Free Oxygen Radical Defence (FORD) in
trained participants and elite athletes and secondly to calculate the analytical, BV, CDV and
index of individuality (II) for FORT, FORD, red blood cell glutathione, lutein, α and γ–tocoph-
erol. Part 1: Fifteen elite athletes were sampled in duplicate for calculation of the repeatabil-
ity of the FORT and FORD tests. Part 2: Twelve well-trained athletes had venous samples
drawn every 2 hours from 0800 to 1800 for calculation of BV, CDV, II for FORT, FORD,
RBC GSH, lutein, α-tocopherol and γ–tocopherol. Results: Repeatability of the FORT and
FORD assay was 3.9% and 3.7% respectively. Biomarker CDV ranged from 12.8% to 37%,
with a circadian effect for FORT, α-tocopherol and γ-tocopherol (p<0.01), with all biomarker
indices of individuality < 0.8 arbitrary units. Conclusion: We report that the use of the novel
redox test in athletes is practical, and the generation of BV and CDV for biomarkers of OS
enhances the interpretation of physiologically meaningful changes in individuals above the
use of clinical reference ranges alone.
PLOS ONE | DOI:10.1371/journal.pone.0149927 March 1, 2016 1 / 12
OPEN ACCESS
Citation: Lewis NA, Newell J, Burden R, Howatson
G, Pedlar CR (2016) Critical Difference and Biological
Variation in Biomarkers of Oxidative Stress and
Nutritional Status in Athletes. PLoS ONE 11(3):
e0149927. doi:10.1371/journal.pone.0149927
Editor: Rodrigo Franco, University of Nebraska-
Lincoln, UNITED STATES
Received: October 29, 2015
Accepted: February 5, 2016
Published: March 1, 2016
Copyright: © 2016 Lewis et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This study was financially supported by the
research support fund in the School of Sport, Health
and Applied Science at St Mary’s University,
Twickenham. The company ORRECO Ltd. had no
role in funding the study, provided support in the form
of salaries for authors N.A.L., C.A.P., and R.B., and
did not have any additional role in the study design,
data collection and analysis, decision to publish, or
preparation of the manuscript. J.N. is a scientific
advisor to ORRECO Ltd. only. ORRECO Ltd. makes
no contribution to his salary.
Introduction
Exercise results in the production of reactive nitrogen and oxygen species (RNOS) and oxida-
tive stress (OS), an effect observed after all types of exercise and consistent across species, and
in different cell types, body fluids and tissues [1,2]. RNOS serve as important signaling mole-
cules in mitochondrial biogenesis [3], glucose transport [4] and muscle hypertrophy [5,6]; thus
having a role in adaptation to exercise. Indeed, exercise training increases endogenous antioxi-
dant enzymes along with biomarkers of cell lipid and protein oxidation, with changes propor-
tional to training volume and load [1,7,8]. The monitoring of OS in elite athletes may enable
the identification of fatigued states, under performance, and illness [1]. However, the successful
application of OS biomarker monitoring programs in elite sport is hindered by: 1) repeatability
of in-the-field testing tools and the need for rapid turnaround of results; 2) an understanding
of the athletes’ individual biological variation (BV) to elucidate meaningful changes [1,9] and
3) the inherent costs of the analytical methods and the invasive nature of repeated venous sam-
pling. Therefore the monitoring of OS, with a point of care (POC) test, coupled with knowledge
of the specific BV may assist practitioners with exercise prescription, recovery modalities and
dietary interventions.
Several POC tests have been developed for ‘field use’ to measure OS [10]; although conve-
nient, their validity has been questioned [11,12]. The Free Oxygen Radical Test (FORT) is an
indirect measure of reactive intermediary by products of in vivo lipid, protein, and nucleic acid
oxidation (hydroperoxides). The Free Oxygen Radical Defence test (FORD) is an indirect mea-
sure of antioxidant capacity, with ascorbic acid, glutathione, and albumin (but not uric acid),
accounting for the majority of antioxidant activity [10]. Together, the FORT and FORD tests
(FFT) provide an index of OS, and this index has been reported to have good reliability [13–
15]. Clinical studies have identified significance differences for FORT values in type-2 diabetics
[15], and in sickle cell disease [16] compared to healthy, age, weight and sex matched controls;
diseases in which OS is a component of the pathophysiology. To date, only one case study has
explored the application of the FFT in elite sport [17], in which elevated OS was demonstrated
in two premier league footballers with sickle cell trait; a condition recognised for disturbed
redox homeostasis and increased OS.
Practitioners, scientists and clinicians are required to decide whether changes are of physio-
logical importance and relevant to athlete health and performance. Most commonly, interpre-
tation of biomarker changes are made within the context of a population-based, reference-
derived value [18]; such an approach has limited value because of biological variation (BV) in
each biomarker. However, critical difference values (CDV), also referred to as a reference
change value, can aid the interpretation of meaningful changes [9,19]. Specifically, calculation
of the BV allows the quantification of random variation and temporal changes around a “set”
point. For a change to be deemed physiologically meaningful in an individual, the difference in
serial numerical results must be greater than the components of variation, referred to as the
CDV. Furthermore, the index of individuality (II) can be used to evaluate the usefulness of
population-based biomarker reference intervals for interpreting meaningful changes in indi-
viduals [18]. To date, no studies have reported the BV for the redox measures, FORT, FORD,
GSH, lutein or γ-tocopherol; with recommendations made for the publication of research on
the BV of biomarkers of OS in athletes [1]. Consequently, for the first time, we aimed to: 1)
assess the repeatability of the FFT at rest in elite athletes, and 2) calculate the analytical varia-
tion, BV, CDV, and index of individuality for FFT, RBC GSH, lutein, and α and γ-tocopherol
in well-trained participants.
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Methods
Part 1: Repeatability
Following institutional ethical approval, 15 national and internationally ranked (includes
Olympic and world medallists) endurance athletes (n = 8 males and 7 females; age
(mean ± SD) 22 ± 4 y; body mass 72 ± 7.1 kg; height 1.79 ± 0.03 m; _VO2max 66 ± 6.5 ml.kg
-1.
min-1) volunteered to participate. Athletes were free living and attending a national training
centre, not taking any medications, and were subject to United Kingdom Anti-doping controls
and testing procedures. All athletes were tested in the general preparation phase of the annual
cycle and where following nutritional guidelines administered via the English Institute of Sport
system. Testing was carried out between 8 a.m. and 9 a.m. in a fasted, hydrated and rested
state. The following tests were performed after informed consent was obtained as a part of
sports science support provision, with procedures approved by the Internal Review Board of
the English Institute of Sport. Written informed consent being obtained from the athletes.
Blood sampling
Whole blood capillary samples (50 μL for FORD, and 20μL for FORT) were taken from each
ear lobe (duplicate samples), processed and analysed immediately at room temperature in line
with the manufacturer’s instructions (Callegari SpA, Catellani Group, Parma, Italy). Briefly,
heparinized capillary samples are immediately mixed with the reagent, centrifuged and ana-
lysed colorimetrically (CR3000, Callegari SpA, Catellani Group, Parma, Italy).
Biochemical analysis
FORT assay. The presence of reactive oxygen species was determined indirectly through
the FORT test [(Free Oxygen Radicals Testing) Callegari, Palma, Italy]. FORT is a colouri-
metric assay based on the capacity of transition metal ions (Fe3+ /Fe2+) to catalyze the break-
down of hydroperoxides (R-OOH) into derivative radicals [alkoxyl (R-O•) and peroxyl radicals
(R-OO•)] within the biological sample. The application of an acidic buffer to the 20μL capillary
sample, releases the transition metals from associated proteins, which react with the hydroper-
oxides present in the sample, producing the alkoxyl and peroxyl radicals. The derivative radi-
cals are trapped through the addition of a buffered chromogen (reagent; an amine derivative,
CrNH2) and develop into a radical cation in a linear based reaction at a controlled temperature
of 37°C, photometrically detectable at 505nm.
ROOHþ Fe2þ ! RO þ OH þ Fe3þ
ROOHþ Fe3þ ! ROO þHþ þ Fe2þ
RO þ ROO þ 2CrNH2 ! RO þ ROO þ ½CrNH2þ
The intensity of the sample colour correlates with the quantity of radical compounds and
therefore the concentration of hydroperoxides in the biological sample, according to Lambert-
Beer’s law. The results are expressed as equivalent concentrations of H2O2 mmol•L
-1 and lin-
earity ranged from 1.22 to 4.56 mmol•L-1 H2O2.
FORD assay. The FORD test (Callegari, Catellani, Italy) determines the presence of
plasma antioxidants via a colourimetric assay based on the capacity of the sample to reduce a
preformed radical cation. In the presence of an acidic buffer and a suitable oxidant (FeCl3), the
chromogen that contains 4-amino-N,N-diethylaniline sulfate forms a stable and coloured radi-
cal cation, photometrically detectable at 505 nm. The antioxidant compounds present in the
plasma sample reduce the radical cation of the chromogen, quenching the colour, and causing
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a discolouration of the sample, proportional to the concentration of antioxidants present. The
absorbance values generated are compared to standard curves derived from Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), a derivative of vitamin E with
enhanced water solubility. FORD values are reported as Trolox equivalents, mmol•L-1, linearity
ranged from 0.25 to 3.0 mmol•L-1 Trolox.
ChromogenðuncoloredÞ þ oxidant ðFe3þÞ Hþ ! Chromogen: þ ðcolourÞ
Chromogen: þ ðcolourÞ þ AOH ! Chromogenþ ðuncoloredÞ þ AO
Part 2: Biological Variation:
The ethics committee of St Mary’s University approved the study. Twelve well-trained male
participants (n = 12) were recruited (age (mean ± SD) 30 ± 7 y; weight 81.9 ± 8.2 kg; height
1.86 ± 0.1 m). All participants provided written, informed consent following completion of a
health questionnaire. Healthy participants were selected based on recommendations for per-
forming studies on BV [18]. Strict control of environmental factors was undertaken to reduce
variability and control for factors known to disrupt redox homeostasis e.g. exercise [20], high
fat meal [21], infection [22], metabolic disease [23], antioxidant supplements [4]. All partici-
pants abstained from physical exercise, alcohol consumption for 72 hours prior to testing, caf-
feine for 24 hours, and maintained their normal dietary habits the day before testing.
Participants arrived at the laboratory at 7.30 a.m. Venous and capillary blood samples were
collected every two hours through the day at 0800, 1000, 1200, 1400, 1600, 1800 for the analysis
of RBC GSH, α and γ tocopherol, lutein, and the FORT and FORD assay. To minimise sources
of variation the following criteria were applied; fasted on arrival to the laboratory and remain-
ing without food until after the last blood sample was collected at 1800 to control for hormonal
fluctuations; water was allowed ad libitum throughout only, remaining supine on an examina-
tion couch at a comfortable temperature throughout (20–22°C) for a minimum of 20 minutes
prior to each blood draw.
Blood sampling
Blood was sampled at the antecubital vein for a total of six blood draws over 10 hours. For the
RBC GSH a single 5 ml sample of venous blood was collected in a lithium heparin vacutainer
tube (BD system; New Jersey, USA), and for lutein, α and γ tocopherol, a single 5 ml sample of
venous blood collected in a serum separator (SST) vacutainer tube (BD system; New Jersey,
USA). For details on the blood sampling of FFT see part 1 (above). For RBC GSH, lutein, α and
γ tocopherol, assays the samples were centrifuged and aliquots were stored at -50°C for later
analysis. To minimise analytical variance, RBC GSH, lutein, α and γ-tocopherol were analysed
under the same analytical conditions; the same batch of reagents and standards, and by the
same laboratory biochemists using the same analysers.
Biochemical Analysis
Serum α-tocopherol, γ-gamma tocopherol and serum lutein were measured by reverse-phase
high-pressure liquid chromatography (HPLC) on an Agilent 1200 series system (Agilent, Man-
chester, U.K) with ultra-violet/visible detection using a modification of the method of Thurn-
ham et al[24]. Samples were protected from light on analysis to reduce oxidation, and serum
separated for analysis by centrifugation at 3000 rpm for 10 minutes. Calibration was carried
out using pure tocopherol standards (Sigma chemical Co, Poole, Dorset, U.K) dissolved in
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ethanol and a lutein standard (AASC Ltd, Southampton, U.K.) dissolved in hexane/chloro-
form, in which concentrations were derived by scanning ultra-violet spectrophotometry and
applying the molar extinction coefficients for each substance. Quantification involved internal
standardization and dose-response curves established with authentic standards. Serum α-
tocopherol, γ-gamma tocopherol and serum lutein were reported as μmol•L-1. Intra assay CV
were 3.3%, 6.8%, and 3.5% for α-tocopherol, γ-tocopherol and lutein respectively.
RBC GSH was measured by the method of Beutler et al. [25] using the chromogenic reaction
of 5,5-dithiobis-(2-nitrobenzoic acid) (DTNB) with sulphydryl groups. The millimolar extinc-
tion coefficient of the DTNB anion was applied to derive concentrations of GSH in whole
blood and the erythrocyte GSH was calculated using the haematocrit (packed cell volume) of
the blood sample. RBC GSH reported as mmol GSH per litre of red cells, with the intra-assay
CV for RBC GSH of 2.4%.
Statistical Analysis
Numerical (mean ± standard deviation) and graphical summaries (case profile plots) were pro-
vided for each biomarker over time. In addition, plots of the relative change from baseline (%)
were generated for each variable. There was no evidence against normality for the distributions
of each biomarker at each time point. As each response variable of interest (i.e. the set of six bio-
markers) is a continuous variable, a linear mixed model was used to model the change over time.
A random effect for each individual was incorporated in all models and the within-individual
correlation over time was specified as unstructured. The time when the testing was recorded was
modeled as a fixed effect, initially as a categorical variable in order to allow a comparison in the
mean change at each time point and then as a continuous variable in order to compare the slopes
for each biomarker over time. Relationships between biomarker variables were examined using
Pearson correlations. All statistical analyses were carried out using R (version 3.1) and the nlme
package. The significance level was set at alpha = 0.05. Model assumptions were visually assessed
for each response at each time point using residual plots from the fitted model.
Part 1: Analytical variation (CVA)
The analytical coefficient of variation (CVA), the intra-assay CVA (%) were calculated for the
FORT and FORD test using methodology of Fraser and Harris [18]. CVA is calculated using
the following formula:
CVA ¼
SD
X
 100 ð%Þ
Where X = mean and SD = standard deviation
Part 2: Analytical and Biological Variation
The CVA for RBC GSH, lutein, and α and γ-tocopherols were calculated using the formula
above, and derived from duplicate samples. The within subject biological variation (CVw),
between subject variation (CVB), CDV, and index of individuality (II) were calculated accord-
ing to methods of Fraser and Harris [18,19]. A missing value was substituted by the mean
value for that participant in the analysis.
CDV was calculated using the following formula:
CDV ¼ 21=2  Z  ðCVA2 þ CVW2Þ1=2
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Given duplicate samples were run on RBC GSH, lutein, and α and γ-tocopherols, the CDV
was adjusted to the following, where by n2 refers to the number of analytical replicates (dupli-
cates):
CDV for duplicate analysis ¼ 21=2  Z  ðCVA2=n2 þ CVW2Þ1=2
II was calculated using the following formula:
II ¼ ðCVa2 þ CVw2Þ1=2=CVB
Results
Repeatability of FFT (part 1)
The repeatability of the FORT and FORD assay was 3.9% and 3.7% respectively. The FORT
and FORD results for the squad were 1.66 (0.36) mmol•L-1 and 1.76 (0.17) mmol•L-1
respectively.
Analytical, BV, CDV and index of individuality for the FFT (part 2)
A significant effect for time was observed for FORT (p<0.001), γ-tocopherol (p<0.001) and α-
tocopherol (p = 0.002) over the 10-hours, indicating circadian variation (Fig 1).
There was no effect for time for lutein (p = 0.60), RBC GSH (p = 0.52) and FORD
(p = 0.26). Figs 2 and 3 show the temporal effect for FORT and FORD, α- and γ-tocopherols
respectively, expressed as the relative change from baseline.
Table 1 summarises the mean (SD) for the FORT, FORD, RBC GSH, lutein and α and γ-
tocopherols.
Table 2 summarises the analytical and biological variability, CDV and index of individuality
for FORT, FORD, RBC GSH, lutein and α and γ-tocopherols. The analytical variability (CVA
%) for all the biomarkers indicates good precision for the assays (Table 2). The biomarker dis-
playing the greatest analytical (6.8%), biological (12.5%), and between subject variability
(51.4%), and CDV (37%) was γ-tocopherol.
For the redox biomarker FORT, moderate to weak relationships were observed for FORT
and RBC GSH (r = -0.41; p< 0.001), α-tocopherol (r = 0.47; p< 0.001) and lutein (r = -0.24;
p = 0.04) respectively. For plasma FORD, a strong relationship with RBC GSH was observed
for AMmeasures only (p = 0.001; r = 0.62). For biomarkers of nutritional status; strong to
moderate relationships were observed for α-tocopherol and γ-tocopherol (r = 0.78; p< 0.001);
α-tocopherol and lutein (r = 0.37; p = 0.001); γ-tocopherol and lutein (r = 0.41; p< 0.001); and
a weak correlation with RBC GSH and γ-tocopherol (r = 0.23; p = 0.04).
Discussion
We present new information on the BV and accompanying CDV and index of individuality
(II) for the OS and nutritional biomarkers FORT, FORD, RBC GSH, lutein and γ-tocopherol.
Furthermore, we provide evidence of a significant circadian effect for FORT, and serum α and
γ-tocopherol; no effect was observed for the antioxidants lutein, FORD or RBC GSH. A circa-
dian effect for FORT and γ-tocopherol represents a finding not reported elsewhere. The repeat-
ability (CVA) of the POC test for both the FORT (3.9%) and the FORD assay (3.7%), are
comparable with reported laboratory measures of OS and are of sufficient analytical precision
to be used clinically. Indeed, the CVA for FORT shows better precision than that reported for
malondialdehyde (MDA) (6.2%), lipid hydroperoxides (4.6%) plasma isoprostanes (4.5%), and
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protein carbonyls (11.9%) in BV OS research [9,20,26]. The CDV values vary between bio-
markers, with large relative changes required for RBC GSH (>27%), FORD (24%) and γ-
tocopherol (37%) before physiological significance could be confidently stated. For all OS and
Fig 1. Case Profile plot of each biomarker over time with mean (black dot), smoothed trajectory (blue line) and 95% confidence interval displayed
(dark shaded area).
doi:10.1371/journal.pone.0149927.g001
Fig 2. Relative changes (%) from baseline (time point 8:00 AM) for FORT (panel A) and FORD (panel B) over the 10-hours (n = 12). Dark black lines denote
group average (mean) expressed as percentage change from baseline, with grey lines as individual responses. * Significant effect for FORT (panel A) over
time (p<0.001).
doi:10.1371/journal.pone.0149927.g002
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nutritional biomarkers reported here, the II indicates that reference ranges are of limited use in
assessing meaningful changes in serial results in individuals. Interestingly, the participant with
the largest relative increase in FORT (28% over the 10 hours), greater than the FORT RCV of
17% and thus deemed to be of physiological significance, had the lowest concentrations of the
dietary antioxidants, γ-tocopherol, α-tocopherol, and lutein.
The increase in FORT observed over the course of the 10 hours might be explained by an
increased mobilization of free fatty acids (FFA’s) into the circulation to provide energy in the
absence of feeding (12–24 hour fast). Indeed, a positive correlation was observed between
FORT and α-tocopherol, representative of increasing mobilisation of plasma α–tocopherol
from adipose tissue in response to fasting, which is consistent with the observations of others
[27]. Or, the increase in FORT may reflect a circadian effect for OS which is evident indepen-
dent of feeding and has been reported by others for MDA, isoprostanes, and DNA oxidation
[28]. In contrast to our findings, Davison et al. [9] observed no evidence for a circadian effect
for MDA and lipid hydroperoxides over eight-hours in ten healthy fasted participants. The
lack of an effect observed by Davison et al. [9], may result from the lower number of partici-
pants, the reduced period of observation, differences in oxidation by products measured and
the greater analytical variability in the measures.
Given a circadian effect for biomarkers of OS and inflammatory cytokines (IL-6, TNF-α)
and the antioxidant pineal hormone melatonin [29], the use of FFT in conjunction with the
CDVmay provide a means of monitoring the impact of significant disruptions in the circadian
sleep-wake rhythm. Professional and Olympic athletes frequently undertake short- and long-
Fig 3. Relative changes (%) from baseline (time point 8:00 AM) for serum α-tocopherol (panel A) and γ-tocopherol (panel B) over the 10-hours (n = 12). Dark
black lines denote group average (mean) expressed as percentage change from baseline, with grey lines as individual responses. * Significant effect for
serum α-tocopherol (p< 0.001; panel A) and γ-tocopherol (p = 0.002; panel B) over time. P<0.05.
doi:10.1371/journal.pone.0149927.g003
Table 1. Absolute mean ± SD concentrations for FORT, FORD, RBCGSH, lutein, and α and γ-tocopherols.
8am 10am 12pm 2pm 4pm 6pm
FORT (mmol•L-1 H2O2) 1.81 (0.33) 1.84 (0.34) 1.88 (0.33) 1.88 (0.32) 1.94 (0.33) 1.92 (0.29)
FORD (mmol•L-1 Trolox) 1.53 (0.17) 1.52 (0.13) 1.56 (0.18) 1.62 (0.16) 1.63 (0.12) 1.52 (0.13)
γ–tocopherol (μmol•L-1) 2.17 (1.26) 1.97 (1.08) 1.81 (0.96) 1.79 (0.92) 1.60 (0.73) 1.60 (0.73)
α-tocopherol (μmol•L-1) 26.2 (6.4) 26.1 (6.1) 26.4 (6.2) 26.8 (6.6) 26.8 (5.7) 27.5 (6.2)
Lutein (μmol•L-1) 0.52 (0.22) 0.51 (0.22) 0.51 (0.21) 0.51 (0.19) 0.52 (0.21) 0.52 (0.21)
RBC GSH (mmol•L-1) 1.95 (0.39) 1.94 (0.38) 1.80 (0.30) 1.91 (0.28) 1.92 (0.39) 2.00 (0.43)
doi:10.1371/journal.pone.0149927.t001
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haul flights and identifying athletes displaying disruption to their sleep-wake cycle (physiologi-
cal relevant increases OS and inflammation using CDV) would aid athlete management.
Increases in pro-inflammatory cytokines are observed after mild sleep deprivation [30], with
FORT reported to correlate with inflammation (e.g. correlating with increases in high sensitiv-
ity c-reactive protein) [31].
Proposed theoretical mechanisms for the observed elevations in FORT (OS) are: 1) eleva-
tions in FFA oxidation as a result of increased FFA’s in keeping with a 24 hour fast and 2) cou-
pled with reduced ATP demand-substrate oxidation (supine for 12 hours) and thus elevations
in reducing equivalents (nicotinamide adenine dinucleotide; NADH2 and flavin adenine dinu-
cleotide; FADH2) leading to increased mitochondrial superoxide and H2O2 formation and
leak, ultimately elevating the basal levels of hydroperoxides. The generation of reducing equiva-
lents being high during fatty acid metabolism, even at low physiological FFA concentrations
[32] and the rate of mitochondrial H2O2 emission is increased when transitioning from carbo-
hydrate to a high fat diet [33]. In addition, a strong relationship exists between plasma FFA’s
and mitochondrial H2O2 production [34], and a 10-hour fast leads to persistent reductions in
cytosolic GSH/GSSG [33]. We observed a significant inverse relationship between plasma
FORT and RBC GSH concentrations.
To date three other studies have quantified the BV of OS indices and reported the CDV
[9,20,26]. However, to our knowledge, no studies have reported BV or CDV data for FORT,
FORD, RBC GSH, lutein and γ-tocopherol. The CDV we report in well trained participants for
α-tocopherol of 14% is in close agreement with that of 13% reported by Davison et al. [9] in
healthy males; using the same methodology. For FORT, we report an CDV of ~17%, which
contrasts with that of Davison et al. [9] for measures specific to lipid peroxidation, with 28%
for lipid hydroperoxides and 50% for MDA.
Our results demonstrate that laboratory reference ranges are not useful for the interpreta-
tion of OS biomarkers when applied to serial results in individuals, on the basis none of the bio-
markers demonstrated an index of individuality greater than 0.8, with a low of 0.10 for lutein,
and a high of 0.78 for the FORD assay. An index of greater than 1.4 indicates results can be
evaluated usefully against reference ranges [18].
The strengths of this study are the level of methodological pre-analytical control applied to
the participants. Such rigorous controls are a necessary feature of studies on BV to minimize
sources of variability. A limitation of the present study is that participants were all male.
Females were excluded given that oestrogen functions as an antioxidant [35]. In addition, the
inclusion of validated biomarkers of lipid, protein or deoxyribonucleic acid (DNA) oxidative
damage would have enabled deeper interrogation and understanding of the novel FORT assay
in athletes e.g. F2-isoprostanes; advanced oxidation protein products; protein carbonyls or
Table 2. Analytical and biological variation, critical difference values and index of individuality for FORT, FORD, RBCGSH, lutein, and α and γ-
tocopherols.
Biomarker CVA % CVW % CVB % II CDV %
FORT 3.9 5.0 17.3 0.29 17.4
FORD 3.7 7.5 9.6 0.78 23.8
γ-tocopherol 6.8 12.5 51.4 0.24 37.0
α-tocopherol 3.3 4.5 23.4 0.19 14.0
Lutein 3.5 3.9 40.8 0.10 12.8
RBC GSH 2.4 9.6 18.9 0.51 26.9
CVA % = analytical variation, CVW % = within subject, CVB % = between subject variation, II = index of individuality, CDV % = critical difference value
doi:10.1371/journal.pone.0149927.t002
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8-Oxo-2'-deoxyguanosine; for a review in elite athletes see Lewis et al. [1]. In view of the fact
plasma protein carbonyl concentrations have been shown to strongly reflect the redox status of
tissue at rest and after exercise, namely skeletal muscle and heart [36]; the measurement of pro-
tein carbonyls would be recommended for future studies incorporating FORT measures.
We recognise that there are limitations with “total” antioxidant capacity assays (TAC)
because such assays are not representative of the “total” antioxidant network in biological sys-
tems [37]. However, we chose to investigate the FFT, which includes a measure of plasma anti-
oxidant capacity (FORD) because: 1) the FORD assay decreases in diseases of OS and is thus
sensitive to depicting changes in OS; 2) uric acid is not a major component of the antioxidant
activity of the assay; 3) measures of TAC have been shown to decrease with psychological
stress, altitude, intense competition, training load and fatigued states [1,38]; 4) GSH is reported
to contribute to the antioxidant activity of the assay, and thus explain a significant proportion
of the variability in the assay 5) we believe the application of an OS point of care test has poten-
tial utility in elite sport and is worthy of scientific investigation. For plasma FORD, a significant
strong relationship with RBC GSH was observed for a.m. only.
Conclusions
We provide new information on the analytical, BV, II, CDV for biomarkers of OS and nutri-
tional status, to be used for monitoring and assessing meaningful changes in serial results in
individuals in relation to health, exercise and performance. We stress the importance of gener-
ating such data, given that for many biomarkers (notably redox measures), laboratory reference
ranges have poor utility due to BV. In view of a circadian effect for FORT, α and γ-tocopherol,
consideration should be given to the time of day for sampling. Finally, the FFT redox test may
be applied in sports and clinical practice and in the field (e.g. training camps) for the assess-
ment of OS, with the critical difference values published here used to enhance interpretation of
meaningful changes in OS in individuals.
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